Literature DB >> 27549549

Minimally Invasive Periareolar Approach to Unroofed Coronary Sinus Atrial Septal Defect Repair.

Sabin J Bozso1, Aaron Grant2, Ivan Iglesias3, Michael W A Chu4.   

Abstract

Less invasive techniques are commonly used to treat patients with anatomically suitable secundum atrial septal defects; however, repair of more complex atrial septal defects are still performed through sternotomy. Cosmetically appealing periareolar incisions have been used in breast reconstructive surgery and may provide an esthetically superior alternative to the anterolateral minithoracotomy incision used in minimally invasive cardiac surgery. We describe a patient with an unroofed coronary sinus atrial septal defect who underwent successful minimally invasive, endoscopic repair of this defect with autologous pericardial baffle reconstruction of the coronary sinus roof and closure of the interatrial communication through a periareolar approach.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27549549     DOI: 10.1016/j.athoracsur.2016.01.064

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Surgery for primary spontaneous pneumothorax.

Authors:  Christophoros N Foroulis
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Coronary sinus atrial septal defects in adults over the past 20 years at new Tokyo hospital: case series.

Authors:  Haruhiko Sugimori; Tatsuya Nakao; Yuki Ikegaya; Daisuke Iwahashi; Shoichi Tsuda; Nao Kume; Hirokazu Onishi; Sunao Nakamura
Journal:  J Cardiothorac Surg       Date:  2021-05-29       Impact factor: 1.637

3.  Comparative Study between Surgical Repair of Atrial Septal Defect via Median Sternotomy, Right Submammary Thoracotomy, and Right Vertical Infra-Axillary Thoracotomy.

Authors:  Zeng-Rong Luo; Qiang Chen; Ling-Li Yu; Liang-Wan Chen; Zhong-Yao Huang
Journal:  Braz J Cardiovasc Surg       Date:  2020-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.